Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The ECTOPIA trial is a randomized, multicenter, clinical trial to assess elimination of
ventricular premature beats (VPB) with catheter ablation versus optimal anti-arrhythmic drugs
(AAD) treatment with flecainide/verapamil or sotalol.